944906-02-9 Usage
Description
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis a chemical compound with the molecular formula C5H5N3O2. It is a derivative of 1,2,4-oxadiazole and is commonly used in the synthesis of pharmaceuticals and agrochemicals. 1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylhas diverse biological activities, including anti-inflammatory, anticancer, and antibacterial properties. Its unique structure and reactivity make it a valuable building block in organic synthesis, with potential applications in the development of new drugs and agricultural products. Additionally, it has been studied for its potential use in materials science and as an intermediate in the production of specialty chemicals.
Uses
Used in Pharmaceutical Industry:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used as a building block in the synthesis of pharmaceuticals for its diverse biological activities, including anti-inflammatory, anticancer, and antibacterial properties.
Used in Agrochemical Industry:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used as a building block in the synthesis of agrochemicals for its potential applications in the development of new agricultural products.
Used in Materials Science:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used in materials science for its potential applications in the development of new materials.
Used as an Intermediate in Specialty Chemicals Production:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used as an intermediate in the production of specialty chemicals due to its unique structure and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 944906-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,9,0 and 6 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 944906-02:
(8*9)+(7*4)+(6*4)+(5*9)+(4*0)+(3*6)+(2*0)+(1*2)=189
189 % 10 = 9
So 944906-02-9 is a valid CAS Registry Number.
944906-02-9Relevant articles and documents
COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES
-
Page/Page column 101; 102, (2019/07/19)
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.
COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES
-
Page/Page column 99, (2019/07/19)
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.
INTEGRASE INHIBITORS 3
-
Page/Page column 60, (2008/06/13)
The present invention provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Compounds of formula (I) are also provided.
